The FDA announced on Dec. 23, 2014, that Hospira Inc. voluntarily recalled Propofol Injectable Emulsion due to the presence of particulate matter. The recall affects 126,075 vials distributed nationwide.
How to tell if you have it
- Brand: Hospira
- Product: Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10mg/mL), 20 mL Single patient infusion vial
- Contains Benzyl Alcohol
- NDC: 0409-4699-30
- Lot code: 35-844-DJ, Exp 11/01/2015
The hazard
The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration and particulates. Other recent recalls of similar products include the 2026-07-24 American Regent Papaverine HCl Injection Recall, the 2026-07-29 Apollo Care SEMAGLUTIDE 10mg Vial Recall, and the 2026-03-24 GE Healthcare Omnipaque Injection Recall.